
Prime Drugs Pvt Ltd
About Prime Drugs Pvt Ltd
Data last updated:
Prime Drugs Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 29 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1994PTC066190.
The company has an authorised share capital of ₹95.1 Lakh and a paid-up capital of ₹95 Lakh. It is led by directors Sarat Kumar Parsan and Suchitra Parsan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P 6 C I T Rd Schme VI(S), Kolkata, West Bengal, India – 700054.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.48 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.3 Lakh (net margin 2.4%) and EBITDA of ₹2.65 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 91% over three years and 38% over five years.
Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Prime Drugs has one previous CIN (Corporate Identification Number): U02429WB1994PTC066190. The current CIN is U24232WB1994PTC066190, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232WB1994PTC066190 | Current |
| U02429WB1994PTC066190 | Previous |
Contact details
Prime Drugs Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP 6 C I T Rd Schme VI(S), Kolkata, West Bengal, India – 700054
- IndustryFinancial Services, Diversified Financial Services, Brokerage & Trading Services
To see the full contact details of Prime Drugs Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prime Drugs is financial and insurance service. In detail, this covers other financial activities and financial advisory, brokerage and consultancy services. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities | |
| K | Financial and insurance Service | K7 | Financial Advisory, brokerage and Consultancy Services |
To see the full business activity and turnover split of Prime Drugs Pvt Ltd, buy the company report.
Financials of Prime Drugs Pvt Ltd
FY 2025 filings availablePrime Drugs Pvt Ltd reported revenue of ₹96.48 Lakh (up 581% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 581% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prime Drugs Pvt Ltd, buy the company report.
Board of directors of Prime Drugs Pvt Ltd
Prime Drugs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarat Kumar Parsan Also directs: Parsan Enterprises LLP, Parsan Brothers and Beverages Private Limited, Pawanputra Mercantiles Pvt Ltd and 1 more | Director | 01 Apr 2000 | 26 Years 7 Months | Current |
| Suchitra Parsan | Director | 01 Aug 1998 | 28 Years 3 Months | Current |
Peer comparison
Prime Drugs Pvt Ltd is compared with the 4 companies closest to it by revenue in the BFSI industry (Broking Services, Other Financial Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nirbhoy Financial Services Private Limited | ₹96.49 Lakh (FY 2024) | 56.0% | Burdwan, West Bengal, India | |||
| Assefa Livestock Producer Company Limited | ₹96.49 Lakh (FY 2025) | -9.0% | Kariapatti, Tamil Nadu, India | |||
| Prime Drugs Pvt Ltdthis company | ₹96.48 Lakh (FY 2025) | ₹2.3 Lakh | 2.4% | 581.0% | Kolkata, West Bengal, India | |
| Pinkcity Share Trading Company Private Limited | ₹96.46 Lakh (FY 2025) | -9.0% | Jaipur, Rajasthan, India | |||
| DJS Stock and Shares Limited | ₹96.46 Lakh (FY 2025) | 327.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Prime Drugs Pvt Ltd, buy the company report.
Auditor
Prime Drugs Pvt Ltd is audited by GHOSHAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GHOSHAL & CO | FY 2021 | 304154E |
Shareholding
The shareholding of Prime Drugs Pvt Ltd is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Prime Drugs Pvt Ltd, buy the company report.
Legal cases
Prime Drugs Pvt Ltd has 2 court cases on record: 2 filed by Prime Drugs. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Kolkata | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Kolkata | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Prime Drugs Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prime Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Prime Drugs Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Prime Drugs Pvt Ltd has 2 board changes on record since 1998: 2 appointments. The latest: Sarat Kumar Parsan was appointed as Director on 01 Apr 2000.
Frequently asked questions
Prime Drugs is an active private limited company based in Kolkata, West Bengal, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 29 November 1994 (32+ years old) and is registered under CIN U24232WB1994PTC066190.
Prime Drugs has 2 current directors:
- Sarat Kumar Parsan - Director
- Suchitra Parsan - Director
The latest financial statements of Prime Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Prime Drugs is U24232WB1994PTC066190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prime Drugs has 2 court cases on record: 2 filed by the company.
Prime Drugs was incorporated on 29 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Prime Drugs by revenue are Nirbhoy Financial Services Private Limited, Assefa Livestock Producer Company Limited, Pinkcity Share Trading Company Private Limited, DJS Stock and Shares Limited, all in the BFSI industry (Broking Services, Other Financial Services), with the same principal business activity (other financial activities).
Sarat Kumar Parsan was appointed as Director on 01 Apr 2000. Suchitra Parsan was appointed as Director on 01 Aug 1998.
The registered office of Prime Drugs is at P 6 C I T Rd Schme VIS, Kolkata, West Bengal, India – 700054.
Prime Drugs operates in the financial services industry, in the diversified financial services segment.
The compliance status of Prime Drugs is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.

